LeMaitre Vascular LMAT Payment for Contingent Consideration Liability, Financing Activities

Payment for Contingent Consideration Liability, Financing Activities at other companies

TFX

TeleflexTFX

$58K+3.6%

Merit Medical SystemsMMSI

——

Other financials

Income statement

See full

Revenue$66.6M+11.2%

Gross profit$48.4M+16.8%

Operating income$17.8M+40.8%

Net income$15.7M+42.4%

EPS (diluted)$0.68+41.7%

Balance sheet

See full

Cash & equivalents$26.9M+6.0%

Total debt$20.9M+20.6%

Total equity$406.6M+17.0%

Total assets$629.5M+13.2%

Cash flow

See full

Operating cash flow$15.1M+67.0%

CapEx$2.8M+101%

Free cash flow$12.3M+60.8%

Valuation

See full

Market cap$2.1B+31.4%

Enterprise value$2.1B+31.6%

P/E33.7×-1.7×

P/S8.2×+1.1×

Profitability

See full

Gross margin72.4%+3.6pp

Operating margin28.5%+5.1pp

Net margin24.3%+4.4pp

FCF margin30.9%+12.7pp

Returns & leverage

See full

Return on equity16.5%+2.8pp

Debt / equity0.1×0.0×

Current ratio14.3×-2.2×

Where this comes from

Reported directly by LeMaitre Vascular in its filing.

Tagged under the XBRL concept us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities.

The official record: LeMaitre Vascular’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LeMaitre Vascular's payment for contingent consideration liability, financing activities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is LeMaitre Vascular's payment for contingent consideration liability, financing activities?: LeMaitre Vascular (LMAT) reported payment for contingent consideration liability, financing activities of $0 in Q1 2026.
How has LeMaitre Vascular's payment for contingent consideration liability, financing activities changed year-over-year?: LeMaitre Vascular's payment for contingent consideration liability, financing activities decreased by 100.0% year-over-year, from $1.43M to $0.